MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by MediWound Ltd. on February 13, 2023, covering the month of February 2023. The filing serves to disclose open market purchases of the Company's ordinary shares by its officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to disclosure of insider trading activity and does not contain financial performance data.
Material Changes
There are no material changes to financial operations or business conditions reported in this filing. The only disclosed event is the acquisition of company stock by senior management.
Management Commentary and Insider Activity
On February 09, 2023, the following officers purchased shares in compliance with the Company's Insider Trading Policy:
- Officers: Nachum (Homi) Shamir (Chairman of the Board) and Ofer Gonen (CEO).
- Total Shares Purchased: 7,200 ordinary shares.
- Average Price: $13.565 per share.
The contents of this Form 6-K are incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Investor Verification Checklist
- Verify the total number of shares purchased (7,200) and the average price ($13.565) against market data for February 09, 2023.
- Confirm that the transactions were executed in accordance with the Company's Insider Trading Policy.
- Review the referenced Registration Statements (Form S-8 and Form F-3) for details on how these shares are treated within the Company's equity plans.